Pure and Mixed Mucinous Carcinoma of the Breast: A Comparison of Clinical Outcomes and Treatment Results

Mucinous carcinoma Breast carcinoma
DOI: 10.1111/tbj.12621 Publication Date: 2016-06-04T05:22:42Z
ABSTRACT
Mucinous breast carcinoma (MBC) represents approximately 1–6% of all malignant and is divided into pure (PMBC) mixed (MMBC) subtypes. This study presents the comparison clinical characteristics treatment results in 70 patients with PMBC 40 MMBC, treated at a single institution during 25 years. Performed analyses showed that only nodal status was different both Patients MMBC significantly higher incidence axillary metastases to (25% versus 10%, respectively). Instead, 10-year disease-free survival rate significant than (85.7% 65%, p < 0.02, test log rank). Authors own observations data from literature proved should be considered as subtypes mucinous cancer.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (36)